EX-FILING FEES

Calculation of Filing Fee Tables
S-8
Aligos Therapeutics, Inc.

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation Rule	Amount Registered	Proposed Maximum Offering Price Per Unit	Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee
1	Equity	Common stock, $0.0001 par value per share	Other	1,000,000	$ 7.49	$ 7,490,000.00	0.0001531	$ 1,146.72
Total Offering Amounts:						$ 7,490,000.00		$ 1,146.72
Total Fee Offsets:								$ 0.00
Net Fee Due:								$ 1,146.72

Offering Note

¹	(1) Pursuant to Rule 416 of the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of the Registrant's Common Stock ("Common Stock") that become issuable under the Registrant's 2020 Incentive Award Plan (the "2020 Plan") by reason of any stock dividend, stock split or similar transaction effected without the receipt of consideration that results in an increase in the number of the outstanding shares of Common Stock. (2) Represents 1,000,000 shares of Common Stock that became reserved and available for issuance under the 2020 Plan. (3) Estimated in accordance with Rule 457(h) solely for the purpose of calculating the registration fee on the basis of $7.49 per share, which is the average of the high and low prices of Common Stock on August 1, 2025, as reported on the Nasdaq Capital Market. (5) The Registrant does not have any fee offsets.

Table 2: Fee Offset Claims and Sources	☑Not Applicable

		Registrant or Filer Name	Form or Filing Type	File Number	Initial Filing Date	Filing Date	Fee Offset Claimed	Security Type Associated with Fee Offset Claimed	Security Title Associated with Fee Offset Claimed	Unsold Securities Associated with Fee Offset Claimed	Unsold Aggregate Offering Amount Associated with Fee Offset Claimed	Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Fee Offset Sources	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A